1. Cost Assessment of Implementation of Immune Tolerance Induction in Iran 
Abdol Majid Cheraghali, PhD, Peyman Eshghi, MD 
Value in Health Regional Issues 
Volume 1, Issue 1, Pages (May 2012)
DOI: /j.vhri
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2. Fig. 1
Breakeven analysis for the ITI group and on-demand therapy with Novoseven. US $1 = 12,260 rials. ITI, immune tolerance induction.
Value in Health Regional Issues 2012 1, 54-58DOI: ( /j.vhri )
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions